Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus Patients
Clinical trial NCT02786979 · TERMINATED
Trial details
- NCT number
- NCT02786979
- Sponsor
- Astellas Pharma Inc
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2013-01-01
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.